nodes	percent_of_prediction	percent_of_DWPC	metapath
Torasemide—CYP2C19—prostate cancer	0.254	1	CbGaD
Torasemide—CYP2C8—Nilutamide—prostate cancer	0.0522	0.109	CbGbCtD
Torasemide—CYP2C19—Bicalutamide—prostate cancer	0.0438	0.091	CbGbCtD
Torasemide—CYP2C19—Nilutamide—prostate cancer	0.0438	0.091	CbGbCtD
Torasemide—CYP2C8—Abiraterone—prostate cancer	0.0432	0.0899	CbGbCtD
Torasemide—CYP2C9—Nilutamide—prostate cancer	0.0364	0.0757	CbGbCtD
Torasemide—CYP2C9—Bicalutamide—prostate cancer	0.0364	0.0757	CbGbCtD
Torasemide—CYP2C19—Flutamide—prostate cancer	0.0363	0.0754	CbGbCtD
Torasemide—CYP2C8—Cabazitaxel—prostate cancer	0.032	0.0665	CbGbCtD
Torasemide—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0279	0.0579	CbGbCtD
Torasemide—CYP2C9—Estrone—prostate cancer	0.0218	0.0453	CbGbCtD
Torasemide—PTGS1—Etoposide—prostate cancer	0.0203	0.0422	CbGbCtD
Torasemide—CYP2C8—Estradiol—prostate cancer	0.0179	0.0373	CbGbCtD
Torasemide—CYP2C9—Capecitabine—prostate cancer	0.0165	0.0344	CbGbCtD
Torasemide—CYP2C19—Estradiol—prostate cancer	0.0151	0.0313	CbGbCtD
Torasemide—CYP2C19—Prednisone—prostate cancer	0.0129	0.0269	CbGbCtD
Torasemide—CYP2C9—Estradiol—prostate cancer	0.0125	0.026	CbGbCtD
Torasemide—CYP2C8—Etoposide—prostate cancer	0.0117	0.0244	CbGbCtD
Torasemide—SLC12A1—urine—prostate cancer	0.00787	0.263	CbGeAlD
Torasemide—CYP2C19—urine—prostate cancer	0.00383	0.128	CbGeAlD
Torasemide—CYP2C9—urine—prostate cancer	0.00297	0.0993	CbGeAlD
Torasemide—SLC12A1—prostate gland—prostate cancer	0.00282	0.0945	CbGeAlD
Torasemide—SLC12A1—epithelium—prostate cancer	0.00208	0.0694	CbGeAlD
Torasemide—SLC12A1—renal system—prostate cancer	0.00192	0.0644	CbGeAlD
Torasemide—SLC12A1—urethra—prostate cancer	0.00189	0.0633	CbGeAlD
Torasemide—SLC12A1—testis—prostate cancer	0.00124	0.0416	CbGeAlD
Torasemide—PTGS1—prostate gland—prostate cancer	0.000973	0.0326	CbGeAlD
Torasemide—PTGS1—seminal vesicle—prostate cancer	0.000823	0.0275	CbGeAlD
Torasemide—CYP2C8—renal system—prostate cancer	0.000818	0.0274	CbGeAlD
Torasemide—PTGS1—epithelium—prostate cancer	0.000715	0.0239	CbGeAlD
Torasemide—PTGS1—renal system—prostate cancer	0.000663	0.0222	CbGeAlD
Torasemide—CYP2C8—testis—prostate cancer	0.000529	0.0177	CbGeAlD
Torasemide—PTGS1—testis—prostate cancer	0.000429	0.0143	CbGeAlD
Torasemide—PTGS1—lymph node—prostate cancer	0.000311	0.0104	CbGeAlD
Torasemide—Angioedema—Estradiol—prostate cancer	0.000193	0.00141	CcSEcCtD
Torasemide—Dyspepsia—Goserelin—prostate cancer	0.000191	0.0014	CcSEcCtD
Torasemide—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000189	0.00139	CcSEcCtD
Torasemide—Asthenia—Ethinyl Estradiol—prostate cancer	0.000189	0.00139	CcSEcCtD
Torasemide—Syncope—Estradiol—prostate cancer	0.000189	0.00139	CcSEcCtD
Torasemide—Pain—Goserelin—prostate cancer	0.000186	0.00136	CcSEcCtD
Torasemide—Constipation—Goserelin—prostate cancer	0.000186	0.00136	CcSEcCtD
Torasemide—Nausea—Bicalutamide—prostate cancer	0.000185	0.00136	CcSEcCtD
Torasemide—Loss of consciousness—Estradiol—prostate cancer	0.000185	0.00136	CcSEcCtD
Torasemide—Cough—Estradiol—prostate cancer	0.000184	0.00135	CcSEcCtD
Torasemide—Pain—Conjugated Estrogens—prostate cancer	0.000184	0.00135	CcSEcCtD
Torasemide—Constipation—Conjugated Estrogens—prostate cancer	0.000184	0.00135	CcSEcCtD
Torasemide—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.00018	0.00132	CcSEcCtD
Torasemide—Myalgia—Estradiol—prostate cancer	0.00018	0.00132	CcSEcCtD
Torasemide—Chest pain—Estradiol—prostate cancer	0.00018	0.00132	CcSEcCtD
Torasemide—Arthralgia—Estradiol—prostate cancer	0.00018	0.00132	CcSEcCtD
Torasemide—Erythema multiforme—Etoposide—prostate cancer	0.000177	0.0013	CcSEcCtD
Torasemide—Hypokalaemia—Prednisone—prostate cancer	0.000177	0.0013	CcSEcCtD
Torasemide—Leukopenia—Mitoxantrone—prostate cancer	0.000176	0.00129	CcSEcCtD
Torasemide—Dizziness—Ethinyl Estradiol—prostate cancer	0.000174	0.00128	CcSEcCtD
Torasemide—Stevens-Johnson syndrome—Docetaxel—prostate cancer	0.000172	0.00126	CcSEcCtD
Torasemide—Oedema—Estradiol—prostate cancer	0.000172	0.00126	CcSEcCtD
Torasemide—Cough—Mitoxantrone—prostate cancer	0.000171	0.00126	CcSEcCtD
Torasemide—Hyperglycaemia—Capecitabine—prostate cancer	0.00017	0.00125	CcSEcCtD
Torasemide—Shock—Estradiol—prostate cancer	0.000169	0.00124	CcSEcCtD
Torasemide—Vomiting—Ethinyl Estradiol—prostate cancer	0.000168	0.00123	CcSEcCtD
Torasemide—Arthralgia—Mitoxantrone—prostate cancer	0.000167	0.00123	CcSEcCtD
Torasemide—Myalgia—Mitoxantrone—prostate cancer	0.000167	0.00123	CcSEcCtD
Torasemide—Chest pain—Mitoxantrone—prostate cancer	0.000167	0.00123	CcSEcCtD
Torasemide—Stevens-Johnson syndrome—Capecitabine—prostate cancer	0.000167	0.00122	CcSEcCtD
Torasemide—Rash—Ethinyl Estradiol—prostate cancer	0.000166	0.00122	CcSEcCtD
Torasemide—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000166	0.00122	CcSEcCtD
Torasemide—Headache—Ethinyl Estradiol—prostate cancer	0.000165	0.00121	CcSEcCtD
Torasemide—Pancreatitis—Prednisone—prostate cancer	0.000165	0.00121	CcSEcCtD
Torasemide—Oedema—Mitoxantrone—prostate cancer	0.00016	0.00118	CcSEcCtD
Torasemide—Shock—Mitoxantrone—prostate cancer	0.000158	0.00116	CcSEcCtD
Torasemide—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000157	0.00115	CcSEcCtD
Torasemide—Haemoglobin—Docetaxel—prostate cancer	0.000157	0.00115	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000157	0.00115	CcSEcCtD
Torasemide—Nausea—Ethinyl Estradiol—prostate cancer	0.000157	0.00115	CcSEcCtD
Torasemide—Rhinitis—Docetaxel—prostate cancer	0.000156	0.00115	CcSEcCtD
Torasemide—Haemorrhage—Docetaxel—prostate cancer	0.000156	0.00115	CcSEcCtD
Torasemide—Asthenia—Goserelin—prostate cancer	0.000156	0.00114	CcSEcCtD
Torasemide—Insomnia—Estradiol—prostate cancer	0.000156	0.00114	CcSEcCtD
Torasemide—Erectile dysfunction—Prednisone—prostate cancer	0.000155	0.00114	CcSEcCtD
Torasemide—Asthenia—Conjugated Estrogens—prostate cancer	0.000154	0.00113	CcSEcCtD
Torasemide—Hyponatraemia—Epirubicin—prostate cancer	0.000153	0.00112	CcSEcCtD
Torasemide—Gastrointestinal haemorrhage—Epirubicin—prostate cancer	0.000152	0.00112	CcSEcCtD
Torasemide—Haemoglobin—Capecitabine—prostate cancer	0.000152	0.00111	CcSEcCtD
Torasemide—Hyperglycaemia—Prednisone—prostate cancer	0.000152	0.00111	CcSEcCtD
Torasemide—Dyspepsia—Estradiol—prostate cancer	0.000151	0.00111	CcSEcCtD
Torasemide—Rhinitis—Capecitabine—prostate cancer	0.000151	0.00111	CcSEcCtD
Torasemide—Haemorrhage—Capecitabine—prostate cancer	0.000151	0.00111	CcSEcCtD
Torasemide—Hypotension—Mitoxantrone—prostate cancer	0.00015	0.0011	CcSEcCtD
Torasemide—Diarrhoea—Goserelin—prostate cancer	0.000149	0.00109	CcSEcCtD
Torasemide—Erythema multiforme—Docetaxel—prostate cancer	0.000148	0.00108	CcSEcCtD
Torasemide—Constipation—Estradiol—prostate cancer	0.000147	0.00108	CcSEcCtD
Torasemide—Pain—Estradiol—prostate cancer	0.000147	0.00108	CcSEcCtD
Torasemide—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000147	0.00108	CcSEcCtD
Torasemide—Leukopenia—Etoposide—prostate cancer	0.000146	0.00107	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000146	0.00107	CcSEcCtD
Torasemide—Loss of consciousness—Etoposide—prostate cancer	0.000144	0.00105	CcSEcCtD
Torasemide—Dizziness—Goserelin—prostate cancer	0.000144	0.00105	CcSEcCtD
Torasemide—Erythema multiforme—Capecitabine—prostate cancer	0.000143	0.00105	CcSEcCtD
Torasemide—Cough—Etoposide—prostate cancer	0.000143	0.00105	CcSEcCtD
Torasemide—Dizziness—Conjugated Estrogens—prostate cancer	0.000142	0.00104	CcSEcCtD
Torasemide—Dehydration—Epirubicin—prostate cancer	0.000141	0.00104	CcSEcCtD
Torasemide—Hyponatraemia—Doxorubicin—prostate cancer	0.000141	0.00104	CcSEcCtD
Torasemide—Dyspepsia—Mitoxantrone—prostate cancer	0.000141	0.00104	CcSEcCtD
Torasemide—Gastrointestinal haemorrhage—Doxorubicin—prostate cancer	0.000141	0.00103	CcSEcCtD
Torasemide—Chest pain—Etoposide—prostate cancer	0.000139	0.00102	CcSEcCtD
Torasemide—Hypokalaemia—Epirubicin—prostate cancer	0.000138	0.00102	CcSEcCtD
Torasemide—Vomiting—Goserelin—prostate cancer	0.000138	0.00101	CcSEcCtD
Torasemide—Pain—Mitoxantrone—prostate cancer	0.000137	0.00101	CcSEcCtD
Torasemide—Constipation—Mitoxantrone—prostate cancer	0.000137	0.00101	CcSEcCtD
Torasemide—Toxic epidermal necrolysis—Epirubicin—prostate cancer	0.000137	0.00101	CcSEcCtD
Torasemide—Rash—Goserelin—prostate cancer	0.000137	0.001	CcSEcCtD
Torasemide—Dermatitis—Goserelin—prostate cancer	0.000137	0.001	CcSEcCtD
Torasemide—Vomiting—Conjugated Estrogens—prostate cancer	0.000137	0.001	CcSEcCtD
Torasemide—Headache—Goserelin—prostate cancer	0.000136	0.000998	CcSEcCtD
Torasemide—Rash—Conjugated Estrogens—prostate cancer	0.000136	0.000995	CcSEcCtD
Torasemide—Dermatitis—Conjugated Estrogens—prostate cancer	0.000135	0.000994	CcSEcCtD
Torasemide—Haemoglobin—Prednisone—prostate cancer	0.000135	0.000993	CcSEcCtD
Torasemide—Headache—Conjugated Estrogens—prostate cancer	0.000135	0.000989	CcSEcCtD
Torasemide—Haemorrhage—Prednisone—prostate cancer	0.000135	0.000988	CcSEcCtD
Torasemide—Dehydration—Doxorubicin—prostate cancer	0.000131	0.000961	CcSEcCtD
Torasemide—Thrombocytopenia—Etoposide—prostate cancer	0.000131	0.000958	CcSEcCtD
Torasemide—Nausea—Goserelin—prostate cancer	0.000129	0.000946	CcSEcCtD
Torasemide—Pancreatitis—Epirubicin—prostate cancer	0.000129	0.000946	CcSEcCtD
Torasemide—Hypokalaemia—Doxorubicin—prostate cancer	0.000128	0.00094	CcSEcCtD
Torasemide—Nausea—Conjugated Estrogens—prostate cancer	0.000128	0.000937	CcSEcCtD
Torasemide—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	0.000127	0.00093	CcSEcCtD
Torasemide—Hypotension—Etoposide—prostate cancer	0.000125	0.000915	CcSEcCtD
Torasemide—Asthenia—Estradiol—prostate cancer	0.000123	0.000906	CcSEcCtD
Torasemide—Syncope—Docetaxel—prostate cancer	0.000122	0.000894	CcSEcCtD
Torasemide—Leukopenia—Docetaxel—prostate cancer	0.000122	0.000892	CcSEcCtD
Torasemide—Loss of consciousness—Docetaxel—prostate cancer	0.000119	0.000876	CcSEcCtD
Torasemide—Pancreatitis—Doxorubicin—prostate cancer	0.000119	0.000875	CcSEcCtD
Torasemide—Hyperglycaemia—Epirubicin—prostate cancer	0.000119	0.00087	CcSEcCtD
Torasemide—Cough—Docetaxel—prostate cancer	0.000119	0.00087	CcSEcCtD
Torasemide—Syncope—Capecitabine—prostate cancer	0.000118	0.000865	CcSEcCtD
Torasemide—Diarrhoea—Estradiol—prostate cancer	0.000118	0.000864	CcSEcCtD
Torasemide—Leukopenia—Capecitabine—prostate cancer	0.000118	0.000864	CcSEcCtD
Torasemide—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000116	0.000853	CcSEcCtD
Torasemide—Chest pain—Docetaxel—prostate cancer	0.000116	0.000849	CcSEcCtD
Torasemide—Arthralgia—Docetaxel—prostate cancer	0.000116	0.000849	CcSEcCtD
Torasemide—Myalgia—Docetaxel—prostate cancer	0.000116	0.000849	CcSEcCtD
Torasemide—Loss of consciousness—Capecitabine—prostate cancer	0.000116	0.000848	CcSEcCtD
Torasemide—Asthenia—Mitoxantrone—prostate cancer	0.000115	0.000844	CcSEcCtD
Torasemide—Cough—Capecitabine—prostate cancer	0.000115	0.000842	CcSEcCtD
Torasemide—Pain—Etoposide—prostate cancer	0.000114	0.000837	CcSEcCtD
Torasemide—Constipation—Etoposide—prostate cancer	0.000114	0.000837	CcSEcCtD
Torasemide—Dizziness—Estradiol—prostate cancer	0.000114	0.000835	CcSEcCtD
Torasemide—Chest pain—Capecitabine—prostate cancer	0.000112	0.000822	CcSEcCtD
Torasemide—Arthralgia—Capecitabine—prostate cancer	0.000112	0.000822	CcSEcCtD
Torasemide—Myalgia—Capecitabine—prostate cancer	0.000112	0.000822	CcSEcCtD
Torasemide—Oedema—Docetaxel—prostate cancer	0.000111	0.000814	CcSEcCtD
Torasemide—Hyperglycaemia—Doxorubicin—prostate cancer	0.00011	0.000805	CcSEcCtD
Torasemide—Diarrhoea—Mitoxantrone—prostate cancer	0.00011	0.000805	CcSEcCtD
Torasemide—Vomiting—Estradiol—prostate cancer	0.000109	0.000803	CcSEcCtD
Torasemide—Shock—Docetaxel—prostate cancer	0.000109	0.0008	CcSEcCtD
Torasemide—Thrombocytopenia—Docetaxel—prostate cancer	0.000109	0.000797	CcSEcCtD
Torasemide—Rash—Estradiol—prostate cancer	0.000109	0.000796	CcSEcCtD
Torasemide—Dermatitis—Estradiol—prostate cancer	0.000108	0.000796	CcSEcCtD
Torasemide—Headache—Estradiol—prostate cancer	0.000108	0.000791	CcSEcCtD
Torasemide—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000108	0.000789	CcSEcCtD
Torasemide—Oedema—Capecitabine—prostate cancer	0.000107	0.000788	CcSEcCtD
Torasemide—Angioedema—Prednisone—prostate cancer	0.000107	0.000786	CcSEcCtD
Torasemide—Haemoglobin—Epirubicin—prostate cancer	0.000106	0.000776	CcSEcCtD
Torasemide—Shock—Capecitabine—prostate cancer	0.000106	0.000775	CcSEcCtD
Torasemide—Rhinitis—Epirubicin—prostate cancer	0.000105	0.000774	CcSEcCtD
Torasemide—Haemorrhage—Epirubicin—prostate cancer	0.000105	0.000772	CcSEcCtD
Torasemide—Thrombocytopenia—Capecitabine—prostate cancer	0.000105	0.000771	CcSEcCtD
Torasemide—Syncope—Prednisone—prostate cancer	0.000105	0.000771	CcSEcCtD
Torasemide—Hypotension—Docetaxel—prostate cancer	0.000104	0.00076	CcSEcCtD
Torasemide—Loss of consciousness—Prednisone—prostate cancer	0.000103	0.000756	CcSEcCtD
Torasemide—Nausea—Estradiol—prostate cancer	0.000102	0.00075	CcSEcCtD
Torasemide—Vomiting—Mitoxantrone—prostate cancer	0.000102	0.000748	CcSEcCtD
Torasemide—Rash—Mitoxantrone—prostate cancer	0.000101	0.000742	CcSEcCtD
Torasemide—Dermatitis—Mitoxantrone—prostate cancer	0.000101	0.000741	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000101	0.000741	CcSEcCtD
Torasemide—Headache—Mitoxantrone—prostate cancer	0.0001	0.000737	CcSEcCtD
Torasemide—Hypotension—Capecitabine—prostate cancer	0.0001	0.000736	CcSEcCtD
Torasemide—Insomnia—Docetaxel—prostate cancer	0.0001	0.000736	CcSEcCtD
Torasemide—Arthralgia—Prednisone—prostate cancer	9.97e-05	0.000732	CcSEcCtD
Torasemide—Myalgia—Prednisone—prostate cancer	9.97e-05	0.000732	CcSEcCtD
Torasemide—Erythema multiforme—Epirubicin—prostate cancer	9.95e-05	0.00073	CcSEcCtD
Torasemide—Haemoglobin—Doxorubicin—prostate cancer	9.79e-05	0.000718	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Capecitabine—prostate cancer	9.78e-05	0.000718	CcSEcCtD
Torasemide—Rhinitis—Doxorubicin—prostate cancer	9.76e-05	0.000716	CcSEcCtD
Torasemide—Dyspepsia—Docetaxel—prostate cancer	9.76e-05	0.000716	CcSEcCtD
Torasemide—Haemorrhage—Doxorubicin—prostate cancer	9.74e-05	0.000715	CcSEcCtD
Torasemide—Insomnia—Capecitabine—prostate cancer	9.71e-05	0.000712	CcSEcCtD
Torasemide—Asthenia—Etoposide—prostate cancer	9.57e-05	0.000702	CcSEcCtD
Torasemide—Oedema—Prednisone—prostate cancer	9.56e-05	0.000702	CcSEcCtD
Torasemide—Nausea—Mitoxantrone—prostate cancer	9.52e-05	0.000699	CcSEcCtD
Torasemide—Constipation—Docetaxel—prostate cancer	9.48e-05	0.000696	CcSEcCtD
Torasemide—Pain—Docetaxel—prostate cancer	9.48e-05	0.000696	CcSEcCtD
Torasemide—Dyspepsia—Capecitabine—prostate cancer	9.45e-05	0.000693	CcSEcCtD
Torasemide—Shock—Prednisone—prostate cancer	9.4e-05	0.00069	CcSEcCtD
Torasemide—Erythema multiforme—Doxorubicin—prostate cancer	9.21e-05	0.000676	CcSEcCtD
Torasemide—Pain—Capecitabine—prostate cancer	9.18e-05	0.000674	CcSEcCtD
Torasemide—Constipation—Capecitabine—prostate cancer	9.18e-05	0.000674	CcSEcCtD
Torasemide—Diarrhoea—Etoposide—prostate cancer	9.13e-05	0.00067	CcSEcCtD
Torasemide—Tension—Epirubicin—prostate cancer	8.99e-05	0.00066	CcSEcCtD
Torasemide—Nervousness—Epirubicin—prostate cancer	8.9e-05	0.000653	CcSEcCtD
Torasemide—Dizziness—Etoposide—prostate cancer	8.82e-05	0.000647	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Prednisone—prostate cancer	8.71e-05	0.000639	CcSEcCtD
Torasemide—Insomnia—Prednisone—prostate cancer	8.65e-05	0.000635	CcSEcCtD
Torasemide—Vomiting—Etoposide—prostate cancer	8.48e-05	0.000622	CcSEcCtD
Torasemide—Dyspepsia—Prednisone—prostate cancer	8.41e-05	0.000618	CcSEcCtD
Torasemide—Rash—Etoposide—prostate cancer	8.41e-05	0.000617	CcSEcCtD
Torasemide—Dermatitis—Etoposide—prostate cancer	8.4e-05	0.000617	CcSEcCtD
Torasemide—Headache—Etoposide—prostate cancer	8.36e-05	0.000613	CcSEcCtD
Torasemide—Tension—Doxorubicin—prostate cancer	8.32e-05	0.00061	CcSEcCtD
Torasemide—Nervousness—Doxorubicin—prostate cancer	8.23e-05	0.000604	CcSEcCtD
Torasemide—Syncope—Epirubicin—prostate cancer	8.22e-05	0.000603	CcSEcCtD
Torasemide—Leukopenia—Epirubicin—prostate cancer	8.2e-05	0.000602	CcSEcCtD
Torasemide—Constipation—Prednisone—prostate cancer	8.17e-05	0.0006	CcSEcCtD
Torasemide—Loss of consciousness—Epirubicin—prostate cancer	8.05e-05	0.000591	CcSEcCtD
Torasemide—Cough—Epirubicin—prostate cancer	7.99e-05	0.000587	CcSEcCtD
Torasemide—Asthenia—Docetaxel—prostate cancer	7.95e-05	0.000584	CcSEcCtD
Torasemide—Nausea—Etoposide—prostate cancer	7.92e-05	0.000581	CcSEcCtD
Torasemide—Chest pain—Epirubicin—prostate cancer	7.8e-05	0.000572	CcSEcCtD
Torasemide—Myalgia—Epirubicin—prostate cancer	7.8e-05	0.000572	CcSEcCtD
Torasemide—Arthralgia—Epirubicin—prostate cancer	7.8e-05	0.000572	CcSEcCtD
Torasemide—Asthenia—Capecitabine—prostate cancer	7.7e-05	0.000565	CcSEcCtD
Torasemide—Syncope—Doxorubicin—prostate cancer	7.6e-05	0.000558	CcSEcCtD
Torasemide—Leukopenia—Doxorubicin—prostate cancer	7.59e-05	0.000557	CcSEcCtD
Torasemide—Diarrhoea—Docetaxel—prostate cancer	7.58e-05	0.000557	CcSEcCtD
Torasemide—Oedema—Epirubicin—prostate cancer	7.48e-05	0.000549	CcSEcCtD
Torasemide—Loss of consciousness—Doxorubicin—prostate cancer	7.45e-05	0.000547	CcSEcCtD
Torasemide—Cough—Doxorubicin—prostate cancer	7.4e-05	0.000543	CcSEcCtD
Torasemide—Shock—Epirubicin—prostate cancer	7.36e-05	0.00054	CcSEcCtD
Torasemide—Diarrhoea—Capecitabine—prostate cancer	7.34e-05	0.000539	CcSEcCtD
Torasemide—Dizziness—Docetaxel—prostate cancer	7.33e-05	0.000538	CcSEcCtD
Torasemide—Thrombocytopenia—Epirubicin—prostate cancer	7.32e-05	0.000537	CcSEcCtD
Torasemide—Chest pain—Doxorubicin—prostate cancer	7.22e-05	0.00053	CcSEcCtD
Torasemide—Arthralgia—Doxorubicin—prostate cancer	7.22e-05	0.00053	CcSEcCtD
Torasemide—Myalgia—Doxorubicin—prostate cancer	7.22e-05	0.00053	CcSEcCtD
Torasemide—Dizziness—Capecitabine—prostate cancer	7.1e-05	0.000521	CcSEcCtD
Torasemide—Vomiting—Docetaxel—prostate cancer	7.05e-05	0.000517	CcSEcCtD
Torasemide—Rash—Docetaxel—prostate cancer	6.99e-05	0.000513	CcSEcCtD
Torasemide—Hypotension—Epirubicin—prostate cancer	6.99e-05	0.000513	CcSEcCtD
Torasemide—Dermatitis—Docetaxel—prostate cancer	6.98e-05	0.000512	CcSEcCtD
Torasemide—Headache—Docetaxel—prostate cancer	6.94e-05	0.00051	CcSEcCtD
Torasemide—Oedema—Doxorubicin—prostate cancer	6.92e-05	0.000508	CcSEcCtD
Torasemide—Asthenia—Prednisone—prostate cancer	6.86e-05	0.000503	CcSEcCtD
Torasemide—Vomiting—Capecitabine—prostate cancer	6.82e-05	0.000501	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Epirubicin—prostate cancer	6.81e-05	0.0005	CcSEcCtD
Torasemide—Shock—Doxorubicin—prostate cancer	6.81e-05	0.0005	CcSEcCtD
Torasemide—Thrombocytopenia—Doxorubicin—prostate cancer	6.77e-05	0.000497	CcSEcCtD
Torasemide—Rash—Capecitabine—prostate cancer	6.77e-05	0.000497	CcSEcCtD
Torasemide—Insomnia—Epirubicin—prostate cancer	6.76e-05	0.000496	CcSEcCtD
Torasemide—Dermatitis—Capecitabine—prostate cancer	6.76e-05	0.000496	CcSEcCtD
Torasemide—Headache—Capecitabine—prostate cancer	6.72e-05	0.000493	CcSEcCtD
Torasemide—Nausea—Docetaxel—prostate cancer	6.58e-05	0.000483	CcSEcCtD
Torasemide—Dyspepsia—Epirubicin—prostate cancer	6.58e-05	0.000483	CcSEcCtD
Torasemide—Diarrhoea—Prednisone—prostate cancer	6.54e-05	0.00048	CcSEcCtD
Torasemide—Hypotension—Doxorubicin—prostate cancer	6.46e-05	0.000474	CcSEcCtD
Torasemide—Pain—Epirubicin—prostate cancer	6.39e-05	0.000469	CcSEcCtD
Torasemide—Constipation—Epirubicin—prostate cancer	6.39e-05	0.000469	CcSEcCtD
Torasemide—Nausea—Capecitabine—prostate cancer	6.37e-05	0.000468	CcSEcCtD
Torasemide—Dizziness—Prednisone—prostate cancer	6.32e-05	0.000464	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Doxorubicin—prostate cancer	6.3e-05	0.000463	CcSEcCtD
Torasemide—Insomnia—Doxorubicin—prostate cancer	6.26e-05	0.000459	CcSEcCtD
Torasemide—Dyspepsia—Doxorubicin—prostate cancer	6.09e-05	0.000447	CcSEcCtD
Torasemide—Vomiting—Prednisone—prostate cancer	6.08e-05	0.000446	CcSEcCtD
Torasemide—Rash—Prednisone—prostate cancer	6.03e-05	0.000442	CcSEcCtD
Torasemide—Dermatitis—Prednisone—prostate cancer	6.02e-05	0.000442	CcSEcCtD
Torasemide—Headache—Prednisone—prostate cancer	5.99e-05	0.00044	CcSEcCtD
Torasemide—Constipation—Doxorubicin—prostate cancer	5.92e-05	0.000434	CcSEcCtD
Torasemide—Pain—Doxorubicin—prostate cancer	5.92e-05	0.000434	CcSEcCtD
Torasemide—Nausea—Prednisone—prostate cancer	5.68e-05	0.000417	CcSEcCtD
Torasemide—Asthenia—Epirubicin—prostate cancer	5.36e-05	0.000394	CcSEcCtD
Torasemide—Diarrhoea—Epirubicin—prostate cancer	5.12e-05	0.000375	CcSEcCtD
Torasemide—Asthenia—Doxorubicin—prostate cancer	4.96e-05	0.000364	CcSEcCtD
Torasemide—Dizziness—Epirubicin—prostate cancer	4.94e-05	0.000363	CcSEcCtD
Torasemide—Vomiting—Epirubicin—prostate cancer	4.75e-05	0.000349	CcSEcCtD
Torasemide—Diarrhoea—Doxorubicin—prostate cancer	4.73e-05	0.000347	CcSEcCtD
Torasemide—Rash—Epirubicin—prostate cancer	4.71e-05	0.000346	CcSEcCtD
Torasemide—Dermatitis—Epirubicin—prostate cancer	4.71e-05	0.000346	CcSEcCtD
Torasemide—Headache—Epirubicin—prostate cancer	4.68e-05	0.000344	CcSEcCtD
Torasemide—Dizziness—Doxorubicin—prostate cancer	4.57e-05	0.000336	CcSEcCtD
Torasemide—Nausea—Epirubicin—prostate cancer	4.44e-05	0.000326	CcSEcCtD
Torasemide—Vomiting—Doxorubicin—prostate cancer	4.4e-05	0.000323	CcSEcCtD
Torasemide—Rash—Doxorubicin—prostate cancer	4.36e-05	0.00032	CcSEcCtD
Torasemide—Dermatitis—Doxorubicin—prostate cancer	4.36e-05	0.00032	CcSEcCtD
Torasemide—Headache—Doxorubicin—prostate cancer	4.33e-05	0.000318	CcSEcCtD
Torasemide—Nausea—Doxorubicin—prostate cancer	4.11e-05	0.000302	CcSEcCtD
Torasemide—CYP2C9—Metabolism—LDHB—prostate cancer	1.01e-05	0.000101	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CYP2E1—prostate cancer	1.01e-05	0.000101	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—HSD3B1—prostate cancer	1e-05	0.000101	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—SLC22A3—prostate cancer	1e-05	0.000101	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GSTO1—prostate cancer	9.99e-06	0.0001	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—HSD3B2—prostate cancer	9.99e-06	0.0001	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—NAT2—prostate cancer	9.99e-06	0.0001	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—NQO1—prostate cancer	9.96e-06	0.0001	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP3A5—prostate cancer	9.9e-06	9.96e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—TH—prostate cancer	9.82e-06	9.88e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	9.76e-06	9.82e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CYP3A4—prostate cancer	9.72e-06	9.78e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—prostate cancer	9.7e-06	9.76e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	9.67e-06	9.73e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	9.6e-06	9.66e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—TBXAS1—prostate cancer	9.59e-06	9.65e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTA4—prostate cancer	9.59e-06	9.65e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—LRP2—prostate cancer	9.57e-06	9.63e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PLCB2—prostate cancer	9.57e-06	9.63e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP2C18—prostate cancer	9.57e-06	9.63e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PDHA1—prostate cancer	9.56e-06	9.62e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTA3—prostate cancer	9.56e-06	9.62e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—TCN2—prostate cancer	9.56e-06	9.62e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—UCP3—prostate cancer	9.56e-06	9.62e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CYP1B1—prostate cancer	9.55e-06	9.61e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—P4HB—prostate cancer	9.39e-06	9.45e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	9.37e-06	9.43e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTA2—prostate cancer	9.34e-06	9.4e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GGT1—prostate cancer	9.25e-06	9.31e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ABCG5—prostate cancer	9.23e-06	9.29e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—SULT1A1—prostate cancer	9.23e-06	9.29e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—SLC22A1—prostate cancer	9.13e-06	9.19e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—SLC22A3—prostate cancer	9.12e-06	9.18e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—HSD3B1—prostate cancer	9.12e-06	9.18e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—NCOA1—prostate cancer	9.11e-06	9.17e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	9.03e-06	9.08e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTA1—prostate cancer	9.01e-06	9.07e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CYP19A1—prostate cancer	8.98e-06	9.04e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—NAT2—prostate cancer	8.91e-06	8.97e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—HSD3B2—prostate cancer	8.91e-06	8.97e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTO1—prostate cancer	8.91e-06	8.97e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—SULT2A1—prostate cancer	8.9e-06	8.96e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	8.85e-06	8.9e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—MED12—prostate cancer	8.76e-06	8.81e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—TBXAS1—prostate cancer	8.74e-06	8.8e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTA4—prostate cancer	8.74e-06	8.8e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GNG5—prostate cancer	8.69e-06	8.74e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—RXRA—prostate cancer	8.67e-06	8.72e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	8.57e-06	8.62e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PLCB2—prostate cancer	8.55e-06	8.6e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—LRP2—prostate cancer	8.55e-06	8.6e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP2C18—prostate cancer	8.55e-06	8.6e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	8.54e-06	8.6e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTA2—prostate cancer	8.52e-06	8.57e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	8.43e-06	8.48e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ABCG5—prostate cancer	8.42e-06	8.47e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—SULT1A1—prostate cancer	8.42e-06	8.47e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—P4HB—prostate cancer	8.38e-06	8.43e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—NCOA3—prostate cancer	8.37e-06	8.42e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—COMT—prostate cancer	8.35e-06	8.4e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GSTP1—prostate cancer	8.31e-06	8.36e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	8.22e-06	8.27e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTA1—prostate cancer	8.22e-06	8.27e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ITPR1—prostate cancer	8.18e-06	8.23e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—SLC22A1—prostate cancer	8.15e-06	8.2e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTO1—prostate cancer	8.13e-06	8.18e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—HSD3B2—prostate cancer	8.13e-06	8.18e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—NAT2—prostate cancer	8.13e-06	8.18e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	8.06e-06	8.11e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	8.04e-06	8.09e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—HPGDS—prostate cancer	7.98e-06	8.03e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—SULT2A1—prostate cancer	7.94e-06	7.99e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP2C19—prostate cancer	7.93e-06	7.98e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—MED12—prostate cancer	7.82e-06	7.86e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	7.82e-06	7.86e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PLCB2—prostate cancer	7.79e-06	7.84e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—LRP2—prostate cancer	7.79e-06	7.84e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP2C18—prostate cancer	7.79e-06	7.84e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GNG5—prostate cancer	7.75e-06	7.8e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GSTT1—prostate cancer	7.74e-06	7.79e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ACHE—prostate cancer	7.74e-06	7.79e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—TYMS—prostate cancer	7.72e-06	7.77e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP2A6—prostate cancer	7.65e-06	7.7e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—P4HB—prostate cancer	7.64e-06	7.69e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GSTM1—prostate cancer	7.64e-06	7.68e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	7.62e-06	7.67e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—LPL—prostate cancer	7.5e-06	7.54e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—NCOA3—prostate cancer	7.47e-06	7.52e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—AKR1C3—prostate cancer	7.45e-06	7.49e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—SLC22A1—prostate cancer	7.43e-06	7.48e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PRKACB—prostate cancer	7.41e-06	7.45e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	7.35e-06	7.39e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	7.34e-06	7.39e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP17A1—prostate cancer	7.33e-06	7.38e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—SULT2A1—prostate cancer	7.24e-06	7.29e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CYP1A1—prostate cancer	7.24e-06	7.28e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	7.23e-06	7.27e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ERCC2—prostate cancer	7.18e-06	7.22e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—MED12—prostate cancer	7.13e-06	7.17e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—HPGDS—prostate cancer	7.13e-06	7.17e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GNG5—prostate cancer	7.07e-06	7.11e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—NCOA2—prostate cancer	6.98e-06	7.03e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTT1—prostate cancer	6.91e-06	6.95e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ACHE—prostate cancer	6.91e-06	6.95e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP2A6—prostate cancer	6.83e-06	6.87e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—NCOA3—prostate cancer	6.81e-06	6.85e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	6.81e-06	6.85e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—MTHFR—prostate cancer	6.75e-06	6.79e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	6.69e-06	6.73e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—SLC5A5—prostate cancer	6.66e-06	6.7e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—AKR1C3—prostate cancer	6.65e-06	6.69e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PPARA—prostate cancer	6.62e-06	6.66e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PRKACB—prostate cancer	6.61e-06	6.65e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP17A1—prostate cancer	6.54e-06	6.58e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP2E1—prostate cancer	6.51e-06	6.55e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—HPGDS—prostate cancer	6.5e-06	6.54e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP2C19—prostate cancer	6.46e-06	6.5e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	6.45e-06	6.49e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—NQO1—prostate cancer	6.44e-06	6.47e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—TH—prostate cancer	6.34e-06	6.38e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ACHE—prostate cancer	6.3e-06	6.34e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTT1—prostate cancer	6.3e-06	6.34e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.3e-06	6.34e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP3A4—prostate cancer	6.28e-06	6.31e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	6.24e-06	6.28e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—NCOA2—prostate cancer	6.23e-06	6.27e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP2A6—prostate cancer	6.23e-06	6.27e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CAV1—prostate cancer	6.22e-06	6.26e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	6.21e-06	6.24e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP1B1—prostate cancer	6.17e-06	6.21e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—AKR1C3—prostate cancer	6.06e-06	6.1e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PRKACB—prostate cancer	6.03e-06	6.07e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GGT1—prostate cancer	5.98e-06	6.01e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP17A1—prostate cancer	5.97e-06	6e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—SLC5A5—prostate cancer	5.95e-06	5.98e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.95e-06	5.98e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—NCOA1—prostate cancer	5.89e-06	5.92e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.88e-06	5.92e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP2E1—prostate cancer	5.81e-06	5.84e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP19A1—prostate cancer	5.8e-06	5.84e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—NQO1—prostate cancer	5.74e-06	5.78e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—NCOA2—prostate cancer	5.68e-06	5.72e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PIK3CG—prostate cancer	5.67e-06	5.7e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—TH—prostate cancer	5.66e-06	5.7e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.62e-06	5.66e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP3A4—prostate cancer	5.6e-06	5.64e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—RXRA—prostate cancer	5.6e-06	5.63e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.57e-06	5.61e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP1B1—prostate cancer	5.51e-06	5.54e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.45e-06	5.48e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—SLC5A5—prostate cancer	5.42e-06	5.46e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—COMT—prostate cancer	5.39e-06	5.43e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GSTP1—prostate cancer	5.37e-06	5.4e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—INS—prostate cancer	5.37e-06	5.4e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GGT1—prostate cancer	5.33e-06	5.37e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP2E1—prostate cancer	5.3e-06	5.33e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ITPR1—prostate cancer	5.28e-06	5.31e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CREBBP—prostate cancer	5.26e-06	5.29e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—NCOA1—prostate cancer	5.25e-06	5.29e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—NQO1—prostate cancer	5.24e-06	5.27e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.19e-06	5.22e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP19A1—prostate cancer	5.18e-06	5.21e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—TH—prostate cancer	5.16e-06	5.19e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.13e-06	5.16e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP3A4—prostate cancer	5.11e-06	5.14e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.08e-06	5.11e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP1B1—prostate cancer	5.02e-06	5.05e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—RXRA—prostate cancer	5e-06	5.03e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—TYMS—prostate cancer	4.99e-06	5.02e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PIK3CD—prostate cancer	4.98e-06	5.02e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GSTM1—prostate cancer	4.93e-06	4.96e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GGT1—prostate cancer	4.86e-06	4.89e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.86e-06	4.89e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—LPL—prostate cancer	4.84e-06	4.87e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—COMT—prostate cancer	4.81e-06	4.84e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTP1—prostate cancer	4.79e-06	4.82e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—NCOA1—prostate cancer	4.79e-06	4.82e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP19A1—prostate cancer	4.72e-06	4.75e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ITPR1—prostate cancer	4.71e-06	4.74e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—NOS3—prostate cancer	4.71e-06	4.74e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP1A1—prostate cancer	4.68e-06	4.7e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ERCC2—prostate cancer	4.64e-06	4.67e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.64e-06	4.66e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—RXRA—prostate cancer	4.56e-06	4.58e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—TYMS—prostate cancer	4.45e-06	4.48e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.43e-06	4.46e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTM1—prostate cancer	4.4e-06	4.43e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—COMT—prostate cancer	4.39e-06	4.42e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTP1—prostate cancer	4.37e-06	4.4e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—MTHFR—prostate cancer	4.36e-06	4.39e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PIK3CB—prostate cancer	4.34e-06	4.37e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—LPL—prostate cancer	4.32e-06	4.35e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PTGS2—prostate cancer	4.3e-06	4.33e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ITPR1—prostate cancer	4.3e-06	4.32e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PPARA—prostate cancer	4.28e-06	4.3e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.23e-06	4.25e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP1A1—prostate cancer	4.17e-06	4.2e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ERCC2—prostate cancer	4.14e-06	4.16e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—TYMS—prostate cancer	4.06e-06	4.09e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CAV1—prostate cancer	4.02e-06	4.05e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTM1—prostate cancer	4.01e-06	4.04e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—LPL—prostate cancer	3.94e-06	3.96e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—MTHFR—prostate cancer	3.89e-06	3.91e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.84e-06	3.87e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PPARA—prostate cancer	3.82e-06	3.84e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP1A1—prostate cancer	3.81e-06	3.83e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ERCC2—prostate cancer	3.77e-06	3.8e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PTEN—prostate cancer	3.75e-06	3.78e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PIK3CG—prostate cancer	3.66e-06	3.68e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CAV1—prostate cancer	3.59e-06	3.61e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—EP300—prostate cancer	3.58e-06	3.6e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—MTHFR—prostate cancer	3.55e-06	3.57e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PPARA—prostate cancer	3.48e-06	3.5e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—INS—prostate cancer	3.47e-06	3.49e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.43e-06	3.45e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CREBBP—prostate cancer	3.4e-06	3.42e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CAV1—prostate cancer	3.27e-06	3.29e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PIK3CG—prostate cancer	3.27e-06	3.29e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PIK3CD—prostate cancer	3.22e-06	3.24e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.13e-06	3.15e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—INS—prostate cancer	3.09e-06	3.11e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—NOS3—prostate cancer	3.04e-06	3.06e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CREBBP—prostate cancer	3.03e-06	3.05e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PIK3CG—prostate cancer	2.98e-06	3e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PIK3CD—prostate cancer	2.87e-06	2.89e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—INS—prostate cancer	2.82e-06	2.84e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PIK3CB—prostate cancer	2.81e-06	2.82e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PTGS2—prostate cancer	2.78e-06	2.8e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CREBBP—prostate cancer	2.76e-06	2.78e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—NOS3—prostate cancer	2.71e-06	2.73e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PIK3CA—prostate cancer	2.65e-06	2.66e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PIK3CD—prostate cancer	2.62e-06	2.64e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PIK3CB—prostate cancer	2.5e-06	2.52e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PTGS2—prostate cancer	2.48e-06	2.5e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—NOS3—prostate cancer	2.47e-06	2.49e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PTEN—prostate cancer	2.42e-06	2.44e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—EP300—prostate cancer	2.31e-06	2.33e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PIK3CB—prostate cancer	2.28e-06	2.3e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PTGS2—prostate cancer	2.26e-06	2.28e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PTEN—prostate cancer	2.16e-06	2.18e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—AKT1—prostate cancer	2.16e-06	2.18e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—EP300—prostate cancer	2.06e-06	2.08e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PTEN—prostate cancer	1.97e-06	1.99e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—EP300—prostate cancer	1.88e-06	1.89e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PIK3CA—prostate cancer	1.71e-06	1.72e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.53e-06	1.54e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—AKT1—prostate cancer	1.4e-06	1.41e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.39e-06	1.4e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—AKT1—prostate cancer	1.25e-06	1.26e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—AKT1—prostate cancer	1.14e-06	1.14e-05	CbGpPWpGaD
